← Our Projects
Concluded Project · 2021–2023
SOLVE
Solidarity for Vaccine Equity

An action research project examining Canada's ethical obligations for global collective health — using vaccine nationalism as a lens to re-imagine more equitable global governance.

Goal
Re-imagining governance for a more equitable future
Solidarity for Vaccine Equity · Equity Science Lab · 2024 · equityscience.ca
Project Context

What can we learn from vaccine nationalism?

"We cannot eliminate the pandemic in Canada unless we end it everywhere."

— Government of Canada
What We Do

Examine Canada's ethical obligations for global collective health by leveraging insights from vaccine nationalism and its effects on equitable access to COVID-19 vaccines.

Solidarity for Vaccine Equity · 2024
How We Do It

Mapping Canada's policy trajectory through a systematic equity analysis lens — deliberating over evidence and equity-informed recommendations, and re-imagining what governance considerations can and should inform global solutions.

Solidarity for Vaccine Equity · 2024
What We Believe

"Health equity means all people have a fair chance to reach their full health potential and are not disadvantaged by social, economic, and environmental conditions." — National Collaborating Centre for Determinants of Health

Solidarity for Vaccine Equity · 2024

Pandemics affect collective global health, fueled by viruses that do not follow rules or recognize national borders. As vaccines became available during the COVID-19 pandemic, vaccine nationalism directly contributed to preventable health and economic losses across the world.

Canada's actual policies and actions for global vaccine governance contradicted its rhetoric of global solidarity — revealing an ethical incoherence that continues to shape an inequitable political economy of vaccines.

Recognizing the critical need for cohesive global responses, the SOLVE study looks deeply at how a policy trajectory of vaccine nationalism unfolded. Alongside consideration of ethics and political economy, and using a process of policy analysis and deliberative dialogue, SOLVE offers a platform for learning-driven insights that can inform an evolved global governance for more equitable futures.

Study Design — Four cycles of deliberative dialogue:

Dialogue 1 — Scholars, leaders, health professionals, NGOs
Dialogue 2 — National actors: Canada, LMIC partners, global health groups
Dialogue 3 — Vaccine equity actors, global NGOs
Dialogue 4 — International governance actors, global multilaterals
Solidarity for Vaccine Equity · 2024
The People
Research team & contributors.
Principal Investigator
Katrina Plamondon, PhD RN
University of British Columbia, Okanagan
Leading SOLVE's research design, knowledge synthesis, and deliberative dialogue framework — bringing together researchers across Canada to advance equity-informed global governance recommendations.
Co-Investigators
Ronald Labonté, PhD, FCAHS, HonFFPH
University of Ottawa
Mira Johri, PhD
Université de Montréal
Vardit Ravitsky, PhD
Université de Montréal
Roojin Habibi, JD
York University
Mohammad Karamouzian, PhD, DVM
University of British Columbia
Jenna Dixon, PhD
University of British Columbia, Okanagan
Srinivas Murthy, MD CM, MHS
University of British Columbia
Ben Brisbois, PhD
University of British Columbia
Coordinator
Christine Edet, PhDc
University of Ottawa
Post-Doctoral Fellow
David Walugembe, PhD
University of British Columbia
Research Assistant / Video Creator
Chanel Fu, MSc
McMaster University
Resources & Publications

Evidence that moves.

2022
Deliberative Dialogues

SOLVE Study Team (November 2022). Cycle 1 Report — Equity-responsive practices for governance. Synthesis of deliberative dialogue sessions held September 7 & 14, 2022.

2022
WHO Submission

SOLVE Study Team (December 2022). Integrating Equity Considerations in a Pandemic Instrument. Report submitted to the Intergovernmental Negotiating Body of the World Health Organization.

2023
Pre-Dialogue Concept Note

SOLVE Study Team (Fall 2023). Re-imagining governance for more equitable futures. A synthesis of stakeholder input and analysis of Canada's approach to vaccine governance during the COVID-19 pandemic — provided as a collective point of departure for the SOLVE deliberative dialogues.

2023
United Nations Intervention

SOLVE Study Team (May 2023). Intervention delivered at the United Nations High-Level Meeting on Pandemic Prevention, Preparedness & Response.

Supported By
SOLVE is supported by
Canadian Institutes of Health Research (CIHR) University of British Columbia Université de Montréal York University University of Ottawa

Explore more
of our work.

SOLVE is one of several projects through which the Equity Science Lab advances evidence, equity, and action.

All Projects Get In Touch →